92 related articles for article (PubMed ID: 24965390)
1. Mantle cell lymphoma-current literature overview.
Pejcic I; Petkovic I; Vrbic S; Filipovic S; Balic M; Cvetanovic A
J BUON; 2014; 19(2):342-9. PubMed ID: 24965390
[TBL] [Abstract][Full Text] [Related]
2. Paramount therapy for young and fit patients with mantle cell lymphoma: strategies for front-line therapy.
Ye H; Desai A; Huang S; Jung D; Champlin R; Zeng D; Yan F; Nomie K; Romaguera J; Ahmed M; Wang ML
J Exp Clin Cancer Res; 2018 Jul; 37(1):150. PubMed ID: 30005678
[TBL] [Abstract][Full Text] [Related]
3. Targeted Drugs as Maintenance Therapy after Autologous Stem Cell Transplantation in Patients with Mantle Cell Lymphoma.
Yan F; Gopal AK; Graf SA
Pharmaceuticals (Basel); 2017 Mar; 10(1):. PubMed ID: 28287430
[TBL] [Abstract][Full Text] [Related]
4. Mantle cell lymphoma: evolving management strategies.
Campo E; Rule S
Blood; 2015 Jan; 125(1):48-55. PubMed ID: 25499451
[TBL] [Abstract][Full Text] [Related]
5. Current regimens and novel agents for mantle cell lymphoma.
Chen Y; Wang M; Romaguera J
Br J Haematol; 2014 Oct; 167(1):3-18. PubMed ID: 24974852
[TBL] [Abstract][Full Text] [Related]
6. Novel therapies in mantle cell lymphoma: a pathway to chemotherapy-free strategies.
Nastoupil LJ; Koff JL; Flowers CR
Oncology (Williston Park); 2013 Oct; 27 Suppl 2():8-12. PubMed ID: 25374999
[TBL] [Abstract][Full Text] [Related]
7. Treatment strategies in mantle cell lymphoma.
Maddocks K; Blum KA
Cancer Treat Res; 2015; 165():251-70. PubMed ID: 25655613
[TBL] [Abstract][Full Text] [Related]
8. Mantle cell lymphoma: observation to transplantation.
Rajabi B; Sweetenham JW
Ther Adv Hematol; 2015 Feb; 6(1):37-48. PubMed ID: 25642314
[TBL] [Abstract][Full Text] [Related]
9. A breakthrough in mantle cell lymphoma.
Johns Hopkins Med Lett Health After 50; 2014 Feb; 25(15):8. PubMed ID: 25122938
[No Abstract] [Full Text] [Related]
10. Clinical efficacy and safety in relapsed/refractory mantle cell lymphoma: a systematic literature review.
Njue A; Colosia A; Trask PC; Olivares R; Khan S; Abbe A; Police R; Wang J; Ruiz-Soto R; Kaye JA; Awan F
Clin Lymphoma Myeloma Leuk; 2015 Jan; 15(1):1-12.e7. PubMed ID: 25052050
[TBL] [Abstract][Full Text] [Related]
11. Mantle cell lymphoma: state of the art.
Skarbnik AP; Goy AH
Clin Adv Hematol Oncol; 2015 Jan; 13(1):44-55. PubMed ID: 25679973
[TBL] [Abstract][Full Text] [Related]
12. A comprehensive review of lenalidomide therapy for B-cell non-Hodgkin lymphoma.
Witzig TE; Nowakowski GS; Habermann TM; Goy A; Hernandez-Ilizaliturri FJ; Chiappella A; Vitolo U; Fowler N; Czuczman MS
Ann Oncol; 2015 Aug; 26(8):1667-77. PubMed ID: 25712458
[TBL] [Abstract][Full Text] [Related]
13. Lifting the mantle: Unveiling new treatment approaches in relapsed or refractory mantle cell lymphoma.
Mussetti A; Kumar A; Dahi PB; Perales MA; Sauter CS
Blood Rev; 2015 May; 29(3):143-52. PubMed ID: 25468719
[TBL] [Abstract][Full Text] [Related]
14. Emerging therapy for the treatment of mantle cell lymphoma.
Rajguru S; Kahl BS
J Natl Compr Canc Netw; 2014 Sep; 12(9):1311-8; quiz 1318. PubMed ID: 25190697
[TBL] [Abstract][Full Text] [Related]
15. Ibrutinib for the treatment of mantle cell lymphoma.
Shah N; Hutchinson C; Rule S
Expert Rev Hematol; 2014 Oct; 7(5):521-31. PubMed ID: 25158606
[TBL] [Abstract][Full Text] [Related]
16. Ibrutinib inhibits collagen-mediated but not ADP-mediated platelet aggregation.
Kamel S; Horton L; Ysebaert L; Levade M; Burbury K; Tan S; Cole-Sinclair M; Reynolds J; Filshie R; Schischka S; Khot A; Sandhu S; Keating MJ; Nandurkar H; Tam CS
Leukemia; 2015 Apr; 29(4):783-7. PubMed ID: 25138588
[TBL] [Abstract][Full Text] [Related]
17. [Mantle cell lymphoma: Towards a personalized therapeutic strategy?].
Navarro Matilla B; García-Marco JA
Med Clin (Barc); 2015 Jun; 144(12):553-9. PubMed ID: 25023849
[TBL] [Abstract][Full Text] [Related]
18. The modern approach to mantle cell lymphoma.
Rule S
Hematol Oncol; 2019 Jun; 37 Suppl 1():66-69. PubMed ID: 31187531
[TBL] [Abstract][Full Text] [Related]
19. Mantle cell lymphoma: 2019 update on the diagnosis, pathogenesis, prognostication, and management.
Jain P; Wang M
Am J Hematol; 2019 Jun; 94(6):710-725. PubMed ID: 30963600
[TBL] [Abstract][Full Text] [Related]
20. Current overview and treatment of mantle cell lymphoma.
Schieber M; Gordon LI; Karmali R
F1000Res; 2018; 7():. PubMed ID: 30109020
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
